GlassScriptPhysician profile
Robert D Aiken
NPI 1851372981
$6,674.55
in general payments reported to CMS, 2019-2025
10 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $59.39 · 2021: $138 · 2022: $33.97 · 2023: $6,089 · 2024: $126 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,600 · Food and Beverage: $453 · Travel and Lodging: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,600.00 |
| Food and Beverage | $453.23 |
| Travel and Lodging | $389.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $6,150.94 | 2023-2025 | |
| Novocure INC. | $379.68 | 2020-2025 | Optune, Optune Gio |
| Aucta Pharmaceuticals, INC. | $41.53 | 2025 | Motpoly Xr |
| Telix Pharmaceuticals | $40.47 | 2025 | Illuccix |
| Springworks Therapeutics, INC. | $23.48 | 2025 | Gomekli |
| Medtronic, INC. | $22.47 | 2021 | |
| Caris Mpi, INC. | $15.98 | 2025 | Mi Cancer Seek |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Aiken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.